The U.S. Supreme Court's 2024 ruling in the Purdue Pharma bankruptcy cases generally prohibiting nonconsensual releases of non-debtors in chapter ...

Provisions in chapter 11 plans releasing non-debtors from liability for pre-bankruptcy conduct in exchange for funding for plan distributions ...

Purdue Pharma received approval for the company's disclosure statement tied to its chapter 11 reorganization plan that aims to deliver more than $7.4 billion in cash to creditors to compensate victims ...

Purdue Pharma L.P. filed for Chapter 11 bankruptcy in March in the U.S. Bankruptcy Court for the Southern District of New York.

Purdue Pharma’s $7 billion opioid settlement could advance after states back it The deal calls for members of the Sackler family who own the company to give up ownership and to contribute up to ...

North Carolina will receive almost $150 million from a bankruptcy settlement with Purdue Pharma and former owners the Sackler family. This photo shows pill bottles with messages about OxyContin ...

Purdue Pharma will pay the remaining $900 million once its bankruptcy protections end. Utah’s $57 million cut will add to a $540 million pot of money received through earlier settlements.

Forty-nine U.S. states have signed off on a $7 billion settlement with Purdue Pharma over its marketing of opioid drugs like its prescription Oxycodone. Local governments and individuals must also ...

OxyContin maker Purdue Pharma 's latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it.

OxyContin maker Purdue Pharma 's latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward after every U.S. state involved agreed to it.

Credit: AP The request of U.S. Bankruptcy Court Judge Sean Lane comes about a year after the U.S. Supreme Court rejected a previous version of Purdue’s proposed settlement.